Share

    


In This Section

Resource Library

With the assistance of its Advisory Committee and Partner Organizations, ACCC has developed a curated resource library that incorporates publications, webinars, tools, and other resources that can help care team members with the safe dispensing of multiple myeloma therapies.

Pharmacy Dispensing Resources
  1. Sample Calendar: With the numerous therapies available to treat multiple myeloma, this sample calendar is a guide for giving patients the information they need about their monthly schedule of therapies and medications.
  2. Multiple Myeloma Dispensing Models Webinar Series: This webinar series from ACCC features six on-demand recordings hosted by expert multidisciplinary faculty who explore various dispensing models and effective practices in the care of patients with multiple myeloma.
  3. Treatment Evolution in Multiple Myeloma: This webcast series from The American Journal of Managed Care explores current therapeutic options for multiple myeloma treatment and best practices for dispensing medications during the COVID-19 pandemic.
  4. Addressing Difficulties of the Multiple Myeloma Treatment Continuum: Key opinion leaders expand upon the difficulties that arise from the oral oncolytic dispensary system, including the inadequacy of community centers, time-consuming documentation, inappropriate utilization contingencies, and more.
Journal Articles
  1. Oral Selinexor–Dexamethasone for Triple- Class Refractory Multiple Myeloma
  2. Collaborative Physician-Pharmacist–Managed Multiple Myeloma Clinic Improves Guideline Adherence and Prevents Treatment Delays
  3. Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma (DREAMM-2): A Two-arm, Randomised, Open-label, Phase 2 Study
  4. Lsatuximab Plus Pomalidomide and Low-dose Dexamethasone Versus Pomalidomide and Low-dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma (ICARIA-MM): a Randomised, Multicentre, Open-label, Phase 3 Study
Patient Resources
  • Cancer and Your Finances Booklet: This booklet describes health insurance options and resources to help patients and their families who are coping with the financial aspects of cancer care and includes worksheets to help you stay organized.
  • Dental and Oral Complications of Treatment - Facts:  Review this factsheet to understand the dental and oral complications of cancer treatment, and what you should do before and during treatment.  
  • HealthTree: A patient-centric disease navigation and research portal.
  • HealthTree University: A comprehensive curriculum about multiple myeloma taught by myeloma specialists for patients, caregivers, and medical professionals (no CME credit).
  • Medication Resource for Blood Cancer Patients: Use this calendar as an easy way for you and your family to manage medications and doctor’s instructions.
  • Minimal/Measurable Residual Disease Chart: Easy-to-read information about Minimal/Measurable Residual Disease (MRD).
  • Minimal Residual Disease: Patient Fact Sheet: This fact sheet provides information about minimal residual disease (MRD), which refers to the small number of cancer cells that remain in the body after treatment.
  • Oral Treatment Adherence Facts: This fact sheet provides information about oral treatment adherence, including tips and resources to help you remember to take your medications.
  • Myeloma Coach: Location to find a team of myeloma patient and caregiver volunteers available to coach, provide guidance in finding a myeloma specialist, learning about financial aid or using online and digital resources that can help one live longer and better with multiple myeloma.  
  • Personalized Support Palm Card: A pamphlet where once can access information specialists provide guidance through financial and social challenges, and give accurate, up-to-date disease, treatment and support information.
  • Leukemia and Lymphoma Society (LLS) Publications
  • The MYELOMA CROWD: An organization that empowers patients with rare diseases at each step of their disease journey – from diagnosis, through education, care and on to a cure.   

Our Partner

Leukemia & Lymphoma Society Logo
HOPA Logo

Our Supporter

Bristol Myers Squibb Logo This project is supported by Bristol Myers Squibb.